Antia Veal has channeled her lifelong love of science into her career in immunology, and exploring disease on the molecular ...

Company reports Q3 2025 AUCATZYL® net product revenue of $21.1 million and deferred revenue of $7.6 million; 60 authorized treatment centers achieved ahead of targetClinical execution and data ...